Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Immunotherapy in NSCLC: Looking Toward the Future
Dr. Jyoti Patel and patient Laura O’Brien share their parting perspectives on stage III non-small cell lung cancer and the future of treatment.
A Team Effort in NSCLC: Support and Information
The value of support and credible information is emphasized regarding one’s journey through non-small cell lung cancer.
Receiving Immunotherapy for Stage III NSCLC
Together with Dr. Jyoti Patel, Laura O’Brien shares insight on her experience of receiving immunotherapy for stage III non-small cell lung cancer.
Stage III NSCLC: Enrolling on a Clinical Trial
Laura O’Brien elucidates her experience of enrolling on a clinical trial following her diagnosis of stage III non-small cell lung cancer.
Improving Treatment Options for Stage III NSCLC
Dr. Jyoti Patel and Laura O’Brien reflect on available treatment options for patients with stage III non-small cell lung cancer, emphasizing the value of clinical trials.
Lauras Diagnosis of Non-Small Cell Lung Cancer
Patient Laura O’Brien shares the story of her diagnosis of non-small cell lung cancer with expert physician Dr. Jyoti Patel.
Immunotherapy Duo Improves Efficacy in Treatment-Resistant Colorectal Cancer
Combining two immunotherapies known as checkpoint inhibitors along with best supportive care prolonged life by two and a half months in patients with advanced colorectal cancer that resisted previous treatments.
The Future of Immunotherapy for Bladder Cancer
Arjun V. Balar, M.D.
An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.
The State of CAR-T Cell Therapy
An expert describes how far the field has come, with two treatments approved and more in the works.
Discussing the Future of Immunotherapy in Non-Small Cell Lung Cancer
One expert weighs in on the use of new immunotherapy agents and combinations in treating non-small cell lung cancer.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: